ALLR

1.42

0.70% -0.01

Handel nachbörslich: 1.44 0.02 +1.41%

Allarity Therapeutics Inc (ALLR)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.43

Offen:

$1.41

24-Stunden-Volumen:

111.24K

Relative Volume:

0.79

Marktkapitalisierung:

$22.59M

Einnahmen:

$345.00K

Nettoeinkommen (Verlust:

$-11.25M

KGV:

-1.9676

EPS:

-0.7217

Netto-Cashflow:

$-16.70M

1W Leistung:

+3.65%

1M Leistung:

+16.39%

6M Leistung:

+54.01%

1J Leistung:

+61.55%

1-Tages-Spanne:

$1.38

$1.4919

1-Wochen-Bereich:

$1.2522

$1.4919

52-Wochen-Spanne:

$0.7687

$2.35

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Firmenname

Allarity Therapeutics Inc

Sektor

Healthcare (1080)

Branche

Biotechnology (604)

Telefon

401-426-4664

Adresse

24 SCHOOL ST., 2ND FLOOR, BOSTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-21

Neueste SEC-Einreichungen

ALLR's Discussions on Twitter

Compare ALLR vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALLR Allarity Therapeutics Inc	1.42	22.75M	345.00K	-11.25M	-16.70M	-0.7217
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-28	Eingeleitet	Ascendiant Capital Markets	Buy

Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten

Aug 19, 2026

Allarity (ALLR) Earnings Update: The Available Earnings Metric Delivers a Beat; Price Move: Shares Move 5.93% Higher for the Current SessionEarnings Seasonality - vinanet.vn

Aug 19, 2026

Aug 15, 2026

Allarity Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 15, 2026

Aug 14, 2026

Allarity Therapeutics Releases Q2 2026 Financial Results - AlphaStreet

Aug 14, 2026

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign - Investing News Network

Aug 14, 2026

Allarity Therapeutics Q2 EPS of $(0.21) beats $(0.25) estimate - scanx.trade

Aug 14, 2026

Allarity Therapeutics reports Q2 results, cash position - Investing.com

Aug 14, 2026

Allarity Therapeutics, Inc. 2026: Revenue $0 Net income ($3.41M), EPS ($0.21) — 10-Q Summary - TradingView

Aug 14, 2026

Allarity Therapeutics reports Q2 results, cash position By Investing.com - Investing.com Canada

Aug 14, 2026

Allarity Therapeutics (ALLR) adds $20M debt, holds $26.9M cash in Q2 2026 - Stock Titan

Aug 14, 2026

Allarity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready ... - Caledonian Record

Aug 14, 2026

Patent Gives Allarity’s Cancer-Drug Pairing Exclusivity Into 2042 - Stock Titan

Aug 14, 2026

ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView

Aug 14, 2026

Aug 13, 2026

Allarity Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Aug 13, 2026

Aug 11, 2026

ALLR Q1 2026 Earnings: Narrower-than-Expected Loss of -$0.17 Highlights Cost DisciplineEarnings Power Value - vinanet.vn

Aug 11, 2026

Aug 06, 2026

Allarity Therapeutics (ALLR) Edges Higher: Biotech Stock Tests Key $1.42 Resistance After +1.5% MoveCup and Handle - vinanet.vn

Aug 06, 2026

Aug 03, 2026

CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView

Aug 03, 2026

Allarity Therapeutics (ALLR) Gains 2.48% as Stock Holds Above Key Support ZoneDividend ETF - dars.gov.et

Aug 03, 2026

Jul 28, 2026